Cargando…
Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization
BACKGROUND: Caffeine exposure modifies the turnover of monoamine neurotransmitters, which play a role in several neuropsychiatric disorders. We conducted a Mendelian randomization study to investigate whether higher plasma caffeine levels are causally associated with the risk of anorexia nervosa, bi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408049/ https://www.ncbi.nlm.nih.gov/pubmed/37553644 http://dx.doi.org/10.1186/s12916-023-03008-0 |
_version_ | 1785086098600361984 |
---|---|
author | Woolf, Benjamin Cronjé, Héléne T. Zagkos, Loukas Burgess, Stephen Gill, Dipender Larsson, Susanna C. |
author_facet | Woolf, Benjamin Cronjé, Héléne T. Zagkos, Loukas Burgess, Stephen Gill, Dipender Larsson, Susanna C. |
author_sort | Woolf, Benjamin |
collection | PubMed |
description | BACKGROUND: Caffeine exposure modifies the turnover of monoamine neurotransmitters, which play a role in several neuropsychiatric disorders. We conducted a Mendelian randomization study to investigate whether higher plasma caffeine levels are causally associated with the risk of anorexia nervosa, bipolar disorder, major depressive disorder (MDD), and schizophrenia. METHODS: Summary-level data on the neuropsychiatric disorders were obtained from large-scale genome-wide association studies (GWASs) of European ancestry participants (n = 72,517 to 807,553) and meta-analyzed with the corresponding data from the FinnGen study (n = 356,077). Summary-level data on plasma caffeine were extracted from a GWAS meta-analysis of 9876 European ancestry individuals. The Mendelian randomization analyses estimated the Wald ratio for each genetic variant and meta-analyzed the variant-specific estimates using multiplicative random effects meta-analysis. RESULTS: After correcting for multiple testing, genetically predicted higher plasma caffeine levels were associated with higher odds of anorexia nervosa (odds ratio [OR] = 1.124; 95% confidence interval [CI] = 1.024–1.238, p(FDR) = 0.039) and a lower odds of bipolar disorder (OR = 0.905, 95% CI = 0.827–0.929, p(FDR) = 0.041) and MDD (OR = 0.965, 95% CI = 0.937–0.995, p(FDR) = 0.039). Instrumented plasma caffeine levels were not associated with schizophrenia (OR = 0.986, 95% CI = 0.929–1.047, p(FDR) = 0.646). CONCLUSIONS: These Mendelian randomization findings indicate that long-term higher plasma caffeine levels may lower the risk of bipolar disorder and MDD but increase the risk of anorexia nervosa. These results warrant further research to explore whether caffeine consumption, supplementation, or abstinence could render clinically relevant therapeutic or preventative psychiatric effects. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-03008-0. |
format | Online Article Text |
id | pubmed-10408049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104080492023-08-09 Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization Woolf, Benjamin Cronjé, Héléne T. Zagkos, Loukas Burgess, Stephen Gill, Dipender Larsson, Susanna C. BMC Med Research Article BACKGROUND: Caffeine exposure modifies the turnover of monoamine neurotransmitters, which play a role in several neuropsychiatric disorders. We conducted a Mendelian randomization study to investigate whether higher plasma caffeine levels are causally associated with the risk of anorexia nervosa, bipolar disorder, major depressive disorder (MDD), and schizophrenia. METHODS: Summary-level data on the neuropsychiatric disorders were obtained from large-scale genome-wide association studies (GWASs) of European ancestry participants (n = 72,517 to 807,553) and meta-analyzed with the corresponding data from the FinnGen study (n = 356,077). Summary-level data on plasma caffeine were extracted from a GWAS meta-analysis of 9876 European ancestry individuals. The Mendelian randomization analyses estimated the Wald ratio for each genetic variant and meta-analyzed the variant-specific estimates using multiplicative random effects meta-analysis. RESULTS: After correcting for multiple testing, genetically predicted higher plasma caffeine levels were associated with higher odds of anorexia nervosa (odds ratio [OR] = 1.124; 95% confidence interval [CI] = 1.024–1.238, p(FDR) = 0.039) and a lower odds of bipolar disorder (OR = 0.905, 95% CI = 0.827–0.929, p(FDR) = 0.041) and MDD (OR = 0.965, 95% CI = 0.937–0.995, p(FDR) = 0.039). Instrumented plasma caffeine levels were not associated with schizophrenia (OR = 0.986, 95% CI = 0.929–1.047, p(FDR) = 0.646). CONCLUSIONS: These Mendelian randomization findings indicate that long-term higher plasma caffeine levels may lower the risk of bipolar disorder and MDD but increase the risk of anorexia nervosa. These results warrant further research to explore whether caffeine consumption, supplementation, or abstinence could render clinically relevant therapeutic or preventative psychiatric effects. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12916-023-03008-0. BioMed Central 2023-08-08 /pmc/articles/PMC10408049/ /pubmed/37553644 http://dx.doi.org/10.1186/s12916-023-03008-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Woolf, Benjamin Cronjé, Héléne T. Zagkos, Loukas Burgess, Stephen Gill, Dipender Larsson, Susanna C. Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization |
title | Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization |
title_full | Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization |
title_fullStr | Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization |
title_full_unstemmed | Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization |
title_short | Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization |
title_sort | appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through mendelian randomization |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408049/ https://www.ncbi.nlm.nih.gov/pubmed/37553644 http://dx.doi.org/10.1186/s12916-023-03008-0 |
work_keys_str_mv | AT woolfbenjamin appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization AT cronjehelenet appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization AT zagkosloukas appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization AT burgessstephen appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization AT gilldipender appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization AT larssonsusannac appraisingthecausalrelationshipbetweenplasmacaffeinelevelsandneuropsychiatricdisordersthroughmendelianrandomization |